Literature DB >> 34024273

Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.

Jung Kwon Kim1, Hwanik Kim1, Hakmin Lee1, Jong Jin Oh1,2, Sangchul Lee1, Sung Kyu Hong1,2, Cheol Kwak2,3, Seok-Soo Byun4,5.   

Abstract

BACKGROUND: There are limited data concerning patients treated with sequential bilateral kidney surgery. Current guidelines still lack an optimal surgical sequencing approach. We evaluated renal functional outcomes after sequential partial nephrectomy (PN) and radical nephrectomy (RN) in patients with bilateral renal cell carcinoma (RCC).
METHODS: A propensity score matched cohort of 267 patients (synchronous bilateral RCCs, N = 44 [88 lesions]; metachronous bilateral, N = 45 [90 lesions]; unilateral, N = 178) from two tertiary institutions were retrospectively analyzed. Synchronous bilateral RCCs were defined as diagnosis concomitantly or within 3 months of former tumor. Renal functional outcomes were defined as estimated glomerular filtration rate (eGFR) changes and de novo chronic kidney disease (CKD, stage ≥3) after surgery. Renal functional outcomes and clinical factors predicting de novo CKD were assessed using descriptive statistics and Cox regression analysis.
RESULTS: In subgroup of bilateral RCCs, patients underwent sequential PN (N = 48), PN followed by RN (N = 8), or RN followed by PN (N = 25). Final postoperative estimated glomerular filtration rates (eGFRs) were 79.4, 41.4, and 61.2 ml/minute/1.73 m2, respectively (p = 0.003). There were significant differences in eGFR decline from baseline and de novo chronic kidney disease (CKD stage ≥ III) among groups, with PN followed by RN group showing the worst functional outcomes (all p <  0.05). Moreover, sequential PN subgroup in bilateral RCC showed significantly higher rate of de novo CKD than unilateral RCC group (13.8% vs. 6.9%, p = 0.016). On multivariate analysis, hypertension (p = 0.010) and surgery sequence (PN followed by RN, p <  0.001) were significant predictors of de novo CKD.
CONCLUSIONS: The surgery sequence should be prudently determined in bilateral renal tumors. PN followed by RN showed a negative impact on renal functional preservation. Nephron-sparing surgery should be considered for all amenable bilateral RCCs.

Entities:  

Keywords:  Bilaterality; Functional outcomes; Partial nephrectomy; Renal cell carcinoma; Sequence of surgery

Year:  2021        PMID: 34024273     DOI: 10.1186/s12885-021-08324-3

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  26 in total

1.  Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes.

Authors:  Matthew N Simmons; Ricardo Brandina; Adrian V Hernandez; Adrian F Hernandez; Inderbir S Gill
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

2.  European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.

Authors:  Börje Ljungberg; Laurance Albiges; Yasmin Abu-Ghanem; Karim Bensalah; Saeed Dabestani; Sergio Fernández-Pello; Rachel H Giles; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Teele Kuusk; Thomas B Lam; Lorenzo Marconi; Axel S Merseburger; Thomas Powles; Michael Staehler; Rana Tahbaz; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2019-02-23       Impact factor: 20.096

3.  Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a population-based cohort study.

Authors:  Nissar Ahmed Sheikh; Mohammed Hassan Khan; Sanjay Pillai; Stephen Lang; Ghulam Nabi
Journal:  Int Urol Nephrol       Date:  2018-02-10       Impact factor: 2.370

4.  Renal Mass and Localized Renal Cancer: AUA Guideline.

Authors:  Steven Campbell; Robert G Uzzo; Mohamad E Allaf; Eric B Bass; Jeffrey A Cadeddu; Anthony Chang; Peter E Clark; Brian J Davis; Ithaar H Derweesh; Leo Giambarresi; Debra A Gervais; Susie L Hu; Brian R Lane; Bradley C Leibovich; Philip M Pierorazio
Journal:  J Urol       Date:  2017-05-04       Impact factor: 7.450

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  Risk of bilateral renal cell cancer.

Authors:  Fredrik Wiklund; Steinar Tretli; Toni K Choueiri; Sabina Signoretti; Katja Fall; Hans-Olov Adami
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

7.  Bilateral synchronous sporadic renal masses: intermediate functional and oncological outcomes at a single institution.

Authors:  Benjamin Woodson; Raul Fernandez; Carrie Stewart; Sree Mandava; Liang Wang; Benjamin R Lee
Journal:  Int Urol Nephrol       Date:  2013-03-26       Impact factor: 2.370

8.  Developments in the surgical management of sporadic synchronous bilateral renal tumours.

Authors:  William T Lowrance; David S Yee; Alexandra C Maschino; Angel M Cronin; Melanie Bernstein; R Houston Thompson; Paul Russo
Journal:  BJU Int       Date:  2009-09-14       Impact factor: 5.588

9.  Bilateral non-familial renal cell carcinoma.

Authors:  G Grimaldi; V Reuter; P Russo
Journal:  Ann Surg Oncol       Date:  1998-09       Impact factor: 5.344

10.  Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.

Authors:  Eric A Singer; Srinivas Vourganti; Kelly Y Lin; Gopal N Gupta; Peter A Pinto; Ardeshir R Rastinehad; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.